BALPHARMA.BO

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Drug Manufacturers - Specialty & Generic

DCF fair valuemodel estimate

Intrinsic value

$141.44

Price

$101.00

Implied upside

+40%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
BALPHARMA.BOBal Pharma Limited	$100.95	-5.97%	$1.6B	—
ACHYUT.BOAchyut Healthcare Ltd.	$6.85	+0.44%	$1.7B	—
DENISCHEM.BODenis Chem Lab Limited	$69.99	-0.67%	$971M	—
FORTISMLR.BOFortis Malar Hospitals Limited	$42.11	-3.64%	$789M	—
KREBSBIO.BOKrebs Biochemicals & Industries Limited	$56.05	-1.08%	$1.2B	—
KREBSBIO.NSKrebs Biochemicals & Industries Limited	$57.80	+2.72%	$1.2B	—
MANGALAM.BOMangalam Drugs & Organics Limited	$31.40	-5.68%	$490M	—

Source: Financial Modeling Prep · peers by sector/industry

Bal Pharma Limited

Bal Pharma Ltd. is a holding company, which engages in the research, development, and commercialization of pharmaceutical products. It offers prescription drugs, generic medicines, and over-the-counter products. The company was founded on May 19, 1987 and is headquartered in Bangalore, India.

www.balpharma.com

Employees: 939
IPO / List date: Jan 2, 2002
HQ: IN

Held by traders on TradeandTell

No one on the platform currently holds BALPHARMA.BO.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in BALPHARMA.BO as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded BALPHARMA.BO yet.